$12.80 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) This Quarter

Retrieved on: 2021-04-18 02:20:35

Tags for this article:

Click the tags to see associated articles and topics

$12.80 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) This Quarter. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 16,259,745 shares of the biotechnology company's stock worth $121,134,000 after purchasing an additional 315,852 shares ...

Article found on: www.marketbeat.com